· Daily · Newsletters
Resonance network: Quantum InsiderSpace Insider
Enveric Biosciences (NASDAQ: ENVB) has announced its decision to solicit Requests-for-Proposal (RFPs) for licensing or selling its PsyAI™ trademark portfolio. The portfolio, managed by its subsidiary Enveric Biosciences Canada, Inc., is no longer strategic
The daily briefing on LinkedIn. Free, one tap to follow.
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.